After you donate
Receipts and supporter access
Monthly supporters can log in, review giving history, download receipts, and manage recurring support with less friction.
Campaign updates
Keep supporters informed, not just thanked.
This page is meant to give supporters something worthwhile after they donate: honest campaign updates, plain-English research summaries, and a predictable rhythm for hearing what happened next.
Update cadence
A clearer communication rhythm
The goal is a better sequence: receipt right away, then meaningful campaign or research updates people actually asked for.
Unique value
Not just a redirect page
We summarize why each medical or research development matters so supporters can understand the story without constantly bouncing away.
What supporters should hear
A healthier follow-up flow.
Immediately: receipt, donor confirmation, and a thank-you that acknowledges the reason for the campaign.
Within a few weeks: a brief note about campaign progress, resources for families, or a local event invitation.
Quarterly: a public campaign recap with funds raised, contribution summaries, and a short research update grounded in credible sources.
Subscribe once
Let people choose what feels helpful.
Research briefs
Recent developments explained in plain English.
These summaries are here to add value on this site itself. Supporters can understand why a development matters first, then choose whether they want to read the full source article or study.
Mar 17, 2026 · NIH
A blood test may help predict symptom timing earlier.
One of the hardest things for families is uncertainty. This NIH-backed work suggests a blood-based biomarker could help estimate when symptoms are likely to emerge, which may eventually help with planning, earlier treatment decisions, and trial enrollment.
Read the NIH articleFeb 27, 2026 · NIH
Researchers found a new biomarker class in blood.
Better biomarkers can mean faster and more precise diagnosis, better sorting of patients into the right trials, and a clearer picture of how the disease is progressing. That matters because earlier and more accurate detection is still one of the biggest barriers in Alzheimer's care.
Read the NIH release2025–2026 · ALZ-NET / Nature Medicine
Real-world treatment learning is finally getting stronger.
Clinical trials matter, but families also need to know how therapies perform in the real world. ALZ-NET and related biomarker work are part of a broader shift toward learning faster from everyday treatment settings, not just tightly controlled studies.